ID   TCCUB
AC   CVCL_WH27
DR   Wikidata; Q98133182
RX   PubMed=28283079;
RX   PubMed=30246405;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
RX   PubMed=28283079; DOI=10.1016/j.tvjl.2017.02.001;
RA   Yoshitake, Ryohei
RA   Saeki, Kohei
RA   Watanabe, Matanobu
RA   Nakaoka, Nanako
RA   Ong, Siew Mei
RA   Hanafusa, Masakazu
RA   Choisunirachon, Nan
RA   Fujita, Naoki
RA   Nishimura, Ryohei
RA   Nakagawa, Takayuki
RT   "Molecular investigation of the direct anti-tumour effects of
RT   nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell
RT   lines.";
RL   Vet. J. 221:38-47(2017).
//
RX   PubMed=30246405; DOI=10.1111/vco.12434;
RA   Sakai, Kosei
RA   Maeda, Shingo
RA   Saeki, Kohei
RA   Nakagawa, Takayuki
RA   Murakami, Mami
RA   Endo, Yoshifumi
RA   Yonezawa, Tomohiro
RA   Kadosawa, Tsuyoshi
RA   Mori, Takashi
RA   Nishimura, Ryohei
RA   Matsuki, Naoaki
RT   "Anti-tumour effect of lapatinib in canine transitional cell carcinoma
RT   cell lines.";
RL   Vet. Comp. Oncol. 16:642-649(2018).
//